|
| U.S. Brand
Names |
|
| Aphrodyne™; Dayto Himbin®;
Yocon®; Yohimex™ |

|
|
| Generic
Available |
|
|
Yes |

|
|
| Synonyms |
|
|
Yohimbine Hydrochloride |

|
|
| Pharmacological Index |
|
|
Miscellaneous Product |

|
|
| Use |
|
|
Unlabeled uses: Treat SSRI-induced sexual dysfunction; weight loss;
impotence; sympathicolytic and mydriatic; may have activity as an
aphrodisiac |

|
|
| Contraindications |
|
|
Renal disease, hypersensitivity to yohimbine |

|
|
| Warnings/Precautions |
|
|
Do not use in pregnancy; do not use in children; not for use in geriatric,
psychiatric, or cardio-renal patients with a history of gastric or duodenal
ulcer; generally not for use in females. Should not be used in kidney disease or
psychiatric disorders; can cause high blood pressure and anxiety, tachycardia,
nausea, or vomiting. |

|
|
| Adverse
Reactions |
|
|
Cardiovascular: Tachycardia, hypertension, hypotension (orthostatic),
flushing
Central nervous system: Anxiety, mania, hallucinations, irritability,
dizziness, psychosis, insomnia, headache, panic attacks
Gastrointestinal: Nausea, vomiting, anorexia, salivation
Neuromuscular & skeletal: Tremors
Miscellaneous: Antidiuretic action, diaphoresis |

|
|
| Drug
Interactions |
|
|
CYP2D6 and 3A3/4 enzyme substrate; CYP2D6 enzyme inhibitor
|

|
|
| Mechanism of
Action |
|
|
Derived from the bark of the yohimbe tree ( Corynanthe yohimbe), this
indole alkaloid produces a presynaptic alpha2-adrenergic blockade.
Peripheral autonomic effect is to increase cholinergic and decrease adrenergic
activity; yohimbine exerts a stimulating effect on the mood and a mild
antidiuretic effect. |

|
|
| Pharmacodynamics/Kinetics |
|
|
Absorption: Oral: 33%
Half-life: 0.6 hour |

|
|
| Usual Dosage |
|
|
Adults: Oral:
Orthostatic hypotension: Doses of 12.5 mg/day have been utilized; however,
more research is necessary |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
Considered unsafe |

|
|
| Dosage Forms |
|
|
Tablet, as hydrochloride: 5.4
mg |

|
|
Copyright © 2007 Drugs Area
|